Clinical Trials Directory

Trials / Completed

CompletedNCT03997006

Is Aminophylline More Effective Than Neostigmine/Atropine Mixture in the Treatment of Post-dural Puncture Headache

Is Aminophylline More Effective Than Neostigmine/Atropine Mixture in the Treatment of Post-dural Puncture Headache: A Randomized Clinical Trial

Status
Completed
Phase
Phase 4
Study type
Interventional
Enrollment
60 (actual)
Sponsor
Damanhour Teaching Hospital · Other Government
Sex
All
Age
21 Years – 50 Years
Healthy volunteers
Not accepted

Summary

Objectives: To compare the safety and efficacy of IV aminophylline versus IV neostigmine/atropine mixture in the treatment of post-dural puncture headache (PDPH). Background: PDPH is the most frequent complication of procedures associated with dural puncture for spinal anesthesia or following accidental dural puncture during epidural anesthesia. Since invasive treatments have known complications, pharmacologic management may be preferable. Patients and Methods: This was a prospective, randomized, double-blind, phase four clinical trial; carried out on 60 patients presented with PDPH at our hospital. Patients were randomly allocated into two equal groups (30 patients each); group A, received IV aminophylline, and group NA, received IV neostigmine/atropine mixture.

Conditions

Interventions

TypeNameDescription
DRUGIV AminophyllineIV Aminophylline (100 mg/8h)
DRUGIV Neostigmine Methylsulfate + Atropine SulphateIV Neostigmine/Atropine mixture (20 μg/kg Neostigmine + 10 μg/kg Atropine)/8h

Timeline

Start date
2019-01-01
Primary completion
2020-01-01
Completion
2020-01-01
First posted
2019-06-25
Last updated
2020-02-05

Locations

1 site across 1 country: Egypt

Source: ClinicalTrials.gov record NCT03997006. Inclusion in this directory is not an endorsement.